Skip to main content

Market Overview

Piper Jaffray Maintains Overweight Rating And PT At $17 On Omnicell (OMCL)

Share:

Piper Jaffray maintained its Overweight rating on Omnicell (NASDAQ: OMCL) in a research report published today. It also left its price target unchanged at $17.

In the report, Piper Jaffray states, "The company reported a penny upside on EPS and in-line revenues by continued expansion in gross margins of both product and service segments, and launched multiple products to increase their competitive advantage. With 41% of the orders coming from new customers and half of them from competitive replacements, we believe the company is gaining market share at a healthy rate. With multiple opportunities for revenue and earnings growth, we like the stock at this valuation. Maintain Overweight, $17 target."

In yesterday's trading, Omnicell's shares were up 1.5% to close the day at $15.61. In today's pre-market trading, its shares traded at $15.80, up 1.22% on Monday's closing value.

 

Related Articles (OMCL)

View Comments and Join the Discussion!

Posted-In: omnicell Piper JaffrayAnalyst Color Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com